Power Law company profile

Karuna Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2009 · IPO 2019 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$11B

Market cap · 2026

Revenue

$654K

Latest reported FY

Investors

8 investors on Karuna Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

PureTech

Steven Paul

Wellcome Trust

ARCH Venture Partners

Series B+ 4 investors entered at this stage

Alexandria Venture Investments

PFM Health Sciences

Pivotal Life Sciences

Eventide Asset Management

Global footprint

Where Karuna Therapeutics has talent and traffic

Web traffic by country

160 monthly visits
across markets

🏳️ Ecuador812.5%

🇺🇸 United States750%

🇬🇷 Greece687.5%

🇬🇧 United Kingdom250%

🇮🇳 India125%

Top 5 markets shown

Patent intelligence

$13M patent portfolio · 13 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$13M

0.11% of market cap · 40.6× smaller than top peer ChemoCentryx ($524M)

13 active patent families

Where Karuna Therapeutics innovates Muscarinics receptorsMedicinal chemistryMuscarinicsXanomelinePharmaceutical drug

Below peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

Karuna Therapeutics on the five Patsnap quality dimensions

Karuna Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Karuna Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Karuna Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Karuna Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo